Structural modifications of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione that improve selectivity for inhibiting the proliferation of melanoma cells containing active ERK signaling

被引：27

作者：

Jung, Kwan-Young ^{[1
]}

Samadani, Ramin ^{[1
]}

Chauhan, Jay ^{[1
]}

Nevels, Kerrick ^{[1
]}

Yap, Jeremy L. ^{[1
]}

Zhang, Jun ^{[1
]}

Worlikar, Shilpa ^{[1
]}

Lanning, Maryanna E. ^{[1
]}

Chen, Lijia ^{[1
]}

Ensey, Mary ^{[2
]}

Shukla, Sagar ^{[1
]}

Salmo, Rosene ^{[3
]}

Heinzl, Geoffrey ^{[1
]}

Gordon, Caryn ^{[4
]}

Dukes, Troy ^{[5
]}

MacKerell, Alexander D., Jr. ^{[1
,6
]}

Shapiro, Paul ^{[1
,6
]}

Fletcher, Steven ^{[1
,6
]}

机构：

[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA

[2] Notre Dame Maryland Univ, Baltimore, MD 21212 USA

[3] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA

[4] Univ Maryland, College Pk, MD 20742 USA

[5] Antioch Diploma Plus High Sch, Baltimore, MD 21218 USA

[6] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA

来源：

ORGANIC & BIOMOLECULAR CHEMISTRY | 2013年 / 11卷 / 22期

基金：

美国国家卫生研究院;

关键词：

TYROSINE KINASE INHIBITORS; RAF/MEK/ERK PATHWAY; MAP KINASES; RESISTANCE; CANCER; BRAF; MUTATIONS; DISCOVERY; DOMAIN; GENE;

D O I：

10.1039/c3ob40199e

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

We herein report on the pharmacophore determination of the ERK docking domain inhibitor (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione, which has led to the discovery of compounds with greater selectivities for inhibiting the proliferation of melanoma cells containing active ERK signaling.

引用

页码：3706 / 3732

页数：27

共 47 条

[11] Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy [J].

Friday, Bret B. ;

Adjei, Alex A. .

CLINICAL CANCER RESEARCH, 2008, 14 (02) :342-346

[12] Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins [J].

Frost, JA ;

Steen, H ;

Shapiro, P ;

Lewis, T ;

Ahn, N ;

Shaw, PE ;

Cobb, MH .

EMBO JOURNAL, 1997, 16 (21) :6426-6438

[13] ABA inhibits germination but not dormancy release in mature imbibed seeds of Lolium rigidum Gaud. [J].

Goggin, Danica E. ;

Steadman, Kathryn J. ;

Emery, R. J. Neil ;

Farrow, Scott C. ;

Benech-Arnold, Roberto L. ;

Powles, Stephen B. .

JOURNAL OF EXPERIMENTAL BOTANY, 2009, 60 (12) :3387-3396

[14] Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in Braf-Mutant Human Cutaneous Melanoma Cells [J].

Gopal, Y. N. Vashisht ;

Deng, Wanleng ;

Woodman, Scott E. ;

Komurov, Kakajan ;

Ram, Prahlad ;

Smith, Paul D. ;

Davies, Michael A. .

CANCER RESEARCH, 2010, 70 (21) :8736-8747

[15] Identification of novel extracellular signal-regulated kinase docking domain inhibitors [J].

Hancock, CN ;

Macias, A ;

Lee, EK ;

Yu, SY ;

MacKerell, AD ;

Shapiro, P .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (14) :4586-4595

[16] ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors [J].

Hatzivassiliou, Georgia ;

Liu, Bonnie ;

O'Brien, Carol ;

Spoerke, Jill M. ;

Hoeflich, Klaus P. ;

Haverty, Peter M. ;

Soriano, Robert ;

Forrest, William F. ;

Heldens, Sherry ;

Chen, Huifen ;

Toy, Karen ;

Ha, Connie ;

Zhou, Wei ;

Song, Kyung ;

Friedman, Lori S. ;

Amler, Lukas C. ;

Hampton, Garret M. ;

Moffat, John ;

Belvin, Marcia ;

Lackner, Mark R. .

MOLECULAR CANCER THERAPEUTICS, 2012, 11 (05) :1143-1154

[17] RAS/MAP KINASE-DEPENDENT AND KINASE-INDEPENDENT SIGNALING PATHWAYS TARGET DISTINCT TERNARY COMPLEX FACTORS [J].

HIPSKIND, RA ;

BUSCHER, D ;

NORDHEIM, A ;

BACCARINI, M .

GENES & DEVELOPMENT, 1994, 8 (15) :1803-1816

[18] Mutation analysis of 24 known cancer genes in the NCI-60 cell line set [J].

Ikediobi, Ogechi N. ;

Davies, Helen ;

Bignell, Graham ;

Edkins, Sarah ;

Stevens, Claire ;

O'Meara, Sarah ;

Santarius, Thomas ;

Avis, Tim ;

Barthorpe, Syd ;

Brackenbury, Lisa ;

Buck, Gemma ;

Butler, Adam ;

Clements, Jody ;

Cole, Jennifer ;

Dicks, Ed ;

Forbes, Simon ;

Gray, Kristian ;

Halliday, Kelly ;

Harrison, Rachel ;

Hills, Katy ;

Hinton, Jonathan ;

Hunter, Chris ;

Jenkinson, Andy ;

Jones, David ;

Kosmidou, Vivienne ;

Lugg, Richard ;

Menzies, Andrew ;

Mironenko, Tatiana ;

Parker, Adrian ;

Perry, Janet ;

Raine, Keiran ;

Richardson, David ;

Shepherd, Rebecca ;

Small, Alex ;

Smith, Raffaella ;

Solomon, Helen ;

Stephens, Philip ;

Teague, Jon ;

Tofts, Calli ;

Varian, Jennifer ;

Webb, Tony ;

West, Sofie ;

Widaa, Sara ;

Yates, Andy ;

Reinhold, William ;

Weinstein, John N. ;

Stratton, Michael R. ;

Futreal, P. Andrew ;

Wooster, Richard .

MOLECULAR CANCER THERAPEUTICS, 2006, 5 (11) :2606-2612

[19]

Iwamoto KS, 1996, CANCER RES, V56, P3862

[20] COT drives resistance to RAF inhibition through MAP kinase pathway reactivation [J].

Johannessen, Cory M. ;

Boehm, Jesse S. ;

Kim, So Young ;

Thomas, Sapana R. ;

Wardwell, Leslie ;

Johnson, Laura A. ;

Emery, Caroline M. ;

Stransky, Nicolas ;

Cogdill, Alexandria P. ;

Barretina, Jordi ;

Caponigro, Giordano ;

Hieronymus, Haley ;

Murray, Ryan R. ;

Salehi-Ashtiani, Kourosh ;

Hill, David E. ;

Vidal, Marc ;

Zhao, Jean J. ;

Yang, Xiaoping ;

Alkan, Ozan ;

Kim, Sungjoon ;

Harris, Jennifer L. ;

Wilson, Christopher J. ;

Myer, Vic E. ;

Finan, Peter M. ;

Root, David E. ;

Roberts, Thomas M. ;

Golub, Todd ;

Flaherty, Keith T. ;

Dummer, Reinhard ;

Weber, Barbara L. ;

Sellers, William R. ;

Schlegel, Robert ;

Wargo, Jennifer A. ;

Hahn, William C. ;

Garraway, Levi A. .

NATURE, 2010, 468 (7326) :968-U370

← 1 2 3 4 5 →